Evidence mapPaperPMID 29449137Full record

ArticleJournal of diabetes and its complications2018

Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort.

Richard J Millstein, Laura L Pyle, Bryan C Bergman, Robert H Eckel, David M Maahs, Marian J Rewers, Irene E Schauer, Janet K Snell-Bergeon

Registry-linked trialAbstract read
In one paragraph

Article in Journal of diabetes and its complications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04133922 (Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04133922 early_phase1withdrawnstarted 2019, after this paper: background citation

Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

Ran2019Enrolled0Registered outcomes5Posted comparisons0ConditionsInsulin Sensitivity/Resistance, Type 1 DiabetesArmsDextrose 20 % in Water, GLP-1, Insulin
Open the trial in the graph
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Barriers to Type 1 Diabetes Adherence in Adolescents.Journal of clinical medicine · 2024
    Review
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Can Resistance Exercise Be a Tool for Healthy Aging in Post-Menopausal Women with Type 1 Diabetes?International journal of environmental research and public health · 2021
    Review
  16. Review
  17. Review
  18. Observational
  19. The Causes of Insulin Resistance in Type 1 Diabetes Mellitus: Is There a Place for Quaternary Prevention?International journal of environmental research and public health · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Richard J MillsteinDivision of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States; Division of Endocrinology, VA Eastern Colorado Health Care System, Denver, CO, United States. Electronic address: Richard.millstein@ucdenver.edu.
Laura L PyleBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, United States; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Electronic address: laura.pyle@ucdenver.edu.
Bryan C BergmanDivision of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States. Electronic address: Bryan.bergman@ucdenver.edu.
Robert H EckelDivision of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States. Electronic address: Robert.Eckel@ucdenver.edu.
David M MaahsBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, United States; Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, United States.. Electronic address: dmaahs@stanford.edu.
Marian J RewersBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Electronic address: Marian.rewers@ucdenver.edu.
Irene E SchauerDivision of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States; Division of Endocrinology, VA Eastern Colorado Health Care System, Denver, CO, United States; Eastern Colorado Geriatric Research, Education, and Clinical Center, United States. Electronic address: Irene.schauer@ucdenver.edu.
Janet K Snell-BergeonBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Electronic address: Janet.snell-bergeon@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USColorado School of Public Health · USUniversity of Colorado Denver · USVA Eastern Colorado Health Care System · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · UNIVERSITY OF COLORADO DENVER · 1985 to 2005
$37.2M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · UNIVERSITY OF COLORADO DENVER · 1995 to 2025
$7.7M
UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · UNIVERSITY OF COLORADO DENVER · 2000 to 2005
$7.4M
SUBCLINICAL HEART DISEASE IN INSULIN-DEPENDENT DIABETESR01HL061753 · UNIVERSITY OF COLORADO DENVER · 1999 to 2005
$3.8M
Determinants of Accelerated CVD in Type 1 DiabetesR01HL079611 · UNIVERSITY OF COLORADO DENVER · 2004 to 2005
$1.2M
NCRR NIH HHS M01 RR000051NHLBI NIH HHS R01 HL061753NHLBI NIH HHS R01 HL079611NHLBI NIH HHS R01 HL113029NIDDK NIH HHS P30 DK048520NIDDK NIH HHS P30 DK057516NIDDK NIH HHS R01 DK116731
6 · The paper itself

Abstract

objectiveTo test the hypothesis that multitissue deficits in insulin sensitivity are greater among women than men with type 1 diabetes compared to respective controls. RESEARCH DESIGN AND

methodsThree-stage hyperinsulinemic-euglycemic clamps (4, 8, 40 mU/m

resultsThere was no difference in age or BMI by type 1 diabetes status in either sex. Free fatty acid rate of appearance (FFA Ra) was higher in both sexes with type 1 diabetes compared to those without diabetes during stages 1 and 2. The same was seen with glycerol for stages 1 and 2. During stage 3 glucose rate of disappearance (Rd) was lower in those with type 1 diabetes among both sexes. All had sex by type 1 diabetes interactions with greater deficits in insulin sensitivity in women. While there was no sex by diabetes interaction in regards to glucose rate of appearance (Ra), those with type 1 diabetes had a higher glucose Ra than those without diabetes.

conclusionsWe found that type 1 diabetes affected adipose and skeletal muscle insulin sensitivity to a greater extent in women than in men, perhaps contributing to the greater relative increase in cardiovascular risk in women with type 1 diabetes.

Indexed as

Insulin ResistanceAdipose TissueAdultCardiovascular DiseasesCohort StudiesDiabetes Mellitus, Type 1FemaleHumansInsulinMaleMiddle AgedMuscle, SkeletalRandom AllocationSex FactorsInsulinCardiovascular diseaseDiabetesGender differencesInsulin resistanceType 1

Identifiers

PMID29449137
PMCPMC5856232
OpenAlexW2783522469

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.